ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,123Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 1000

$632K Total Retail Price of All Prescriptions

Rank: 177 out of 1000

614 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 614 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 614 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 12,402 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 962 745 1 3
OMEPRAZOLE 726 495 2 2
LEVOTHYROXINE SODIUM 585 454 3 4
TRAMADOL HCL 566 379 4 13
AMLODIPINE BESYLATE 562 470 5 6
LISINOPRIL 559 373 6 5
METFORMIN HCL 546 418 7 8
FUROSEMIDE 411 320 8 7
HYDROCODONE-ACETAMINOPHEN 399 213 S3 9 1
POTASSIUM CHLORIDE 337 275 10 10
ATENOLOL 304 238 11 24
CIPROFLOXACIN HCL 286 218 12 46
PRAVASTATIN SODIUM 275 178 13 12
GABAPENTIN 270 181 14 11
HYDROCHLOROTHIAZIDE 245 214 15 9
TRAZODONE HCL 238 154 16 29
CARVEDILOL 233 163 17 15
ATORVASTATIN CALCIUM 210 169 18 18
SERTRALINE HCL 203 138 19 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 200 153 20 20
CITALOPRAM HBR 197 136 21 17
CYCLOBENZAPRINE HCL 173 101 R 22 39
WARFARIN SODIUM 162 114 23 22
METOPROLOL TARTRATE 159 123 24 19
PAROXETINE HCL 150 116 25 63
ZOLPIDEM TARTRATE 148 92 26 16
CLONIDINE HCL 147 130 27 27
FLUTICASONE PROPIONATE 143 93 28 40
ALLOPURINOL 142 100 29 31
PROAIR HFA 142 85 29 50
NAPROXEN 131 80 31 81
PANTOPRAZOLE SODIUM 131 96 31 28
DONEPEZIL HCL 128 123 33 32
GEMFIBROZIL 127 57 34 105
FENOFIBRATE 124 67 35 55
RANITIDINE HCL 124 61 35 37
GLIPIZIDE ER 123 102 37 106
METOPROLOL SUCCINATE 113 110 38 21
NEXIUM 109 85 39 23
FLUOXETINE HCL 106 63 40 51
SPIRIVA 102 84 41 64
LOSARTAN POTASSIUM 101 68 42 25
BENAZEPRIL HCL 100 90 43 61
MECLIZINE HCL 98 82 44 80
CRESTOR 95 75 45 30
CARBIDOPA-LEVODOPA 93 57 46 116
PREDNISONE 92 62 47 42
LANSOPRAZOLE 91 69 48 190
AMITRIPTYLINE HCL 91 25 R 48 45
HYDROXYZINE HCL 86 37 R 50 153
LYRICA 85 56 51 47
CLOPIDOGREL 79 45 52 35
LOVASTATIN 78 69 53 41
TAMSULOSIN HCL 78 74 53 33
ESTRADIOL 76 50 R 55 114
PRIMIDONE 73 46 56 228
LOSARTAN-HYDROCHLOROTHIAZIDE 69 59 57 38
DIOVAN 68 45 58 67
ISOSORBIDE MONONITRATE ER 67 47 59 71
CELEBREX 66 55 60 98
AZITHROMYCIN 66 45 60 36
AMLODIPINE BESYLATE-BENAZEPRIL 66 49 60 59
QUINAPRIL HCL 65 58 63 117
OXYBUTYNIN CHLORIDE 62 62 64 145
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 53 64 70
PROMETHAZINE HCL 62 19 R 64 54
PREMARIN 60 37 R 67 109
LANTUS SOLOSTAR 60 38 67 120
CYMBALTA 60 42 67 53
MELOXICAM 59 55 70 14
ESCITALOPRAM OXALATE 59 38 70 60
GLIMEPIRIDE 58 56 72 34
METHOCARBAMOL 58 36 R 72 79
PROPRANOLOL HCL 57 57 74 135
ENALAPRIL MALEATE 57 55 74 58
SPIRONOLACTONE 56 28 76 78
ALENDRONATE SODIUM 55 44 77 57
DILTIAZEM ER 55 55 77 146
FLUCONAZOLE 54 34 79 102
GLIPIZIDE 54 33 79 62
VENTOLIN HFA 52 33 81 83
RAMIPRIL 51 51 82 77
DIGOXIN 51 27 82 52
TOPIRAMATE 50 19 84 181
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.